Los Angeles Times
Have Acid Reflux and Blood Clot Risk? FDA explores possible drug interaction
4:11 PM, January 26, 2009

The Food and Drug Administration on Monday said it has ordered the makers of the clot-reducing drug clopidogrel -- also known as Plavix -- to conduct studies into the possible interaction of Plavix and a class of acid-reflux medicines called proton pump inhibitors. Until those studies have been assessed by the FDA, federal regulators are advising physicians to reconsider whether to start or continue patients on drug therapy that combines the two drugs.

Read the full article: http://latimesblogs.latimes.com/booster_shots/2009/01/acid-reflux-and.html